SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-000744
Filing Date
2024-01-05
Accepted
2024-01-05 19:58:47
Documents
1
Period of Report
2024-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704502718.html 4  
1 FORM 4 wk-form4_1704502718.xml 4 19072
  Complete submission text file 0001628280-24-000744.txt   20812
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 225 S. LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address
O'Brien Patrick (Reporting) CIK: 0001627183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 24518019